identifeye HEALTH Expands Advisory Leadership to Advance Preventive Diagnostics and AI-Powered Care

identifeye HEALTH, a medical technology company pioneering AI-enabled retinal diagnostics, today announced additions to its Clinical, Commercial and Scientific Advisory Panel. The world-class group of leaders in medicine, science, and technology will guide identifeye’s strategy across clinical validation, workflow integration, patient engagement, and market adoption.

This milestone follows the company’s transition earlier this year into its next phase, bringing its platform into clinical use, returning results to patients, building strategic partnerships, and shaping the roadmap for scale. The panel brings together renowned leaders from medicine, health-system administration, and technology who are helping ensure identifeye HEALTH continues to build on the right foundations for lasting impact.

“As we move from development to real-world implementation, it’s vital that we surround ourselves with leaders who understand both innovation and care delivery,” said Vicky Demas, PhD, founder and CEO of identifeye HEALTH. “This group represents the best of both — individuals who have built and scaled transformative healthcare technologies, led major institutions, and advanced the science behind preventive care. Their experience across clinical care, operations, and health system administration will help us ensure our solutions fit seamlessly into care delivery. Their guidance strengthens our foundation, accelerates adoption, and ultimately makes preventive diagnostics more accessible.”

The expanded advisory panel brings together leaders from major institutions such as Google, GRAIL, Mount Sinai, Massachusetts Institute of Technology (MIT), the Mayo Clinic, Harvard, and Yale, reflecting the company’s multidisciplinary approach to innovation and implementation. Together, these advisors will help guide identifeye’s clinical validation, workflow integration, and commercial strategy as it prepares for broader rollout and growth financing.

“I’ve always believed that true innovation must support clinicians at the front lines of care,” said Dr. Arthur Klein, former President of the Mount Sinai Health Network and adjunct assistant professor at Columbia University, Mailman School of Public Health. “identifeye HEALTH’s platform does exactly that - empowering primary care teams with practical, accessible tools that integrate seamlessly into clinical workflows. Too often, innovations are developed without regard for the daily realities of patient care. I am proud to help guide identifeye HEALTH through commercialization as it brings this technology into practice, supporting clinicians rather than adding burden. I’ve seen firsthand the enthusiasm it inspires, and I am eager to help expand those connections and amplify its impact.”

Over the past year, identifeye HEALTH has advanced from development to real-world implementation, achieving milestones in technology transfer, regulatory readiness, pilot deployments, and community impact. The identifeye Camera, a portable, AI-powered retinal imaging platform, allows frontline care teams to capture high-quality images in minutes and integrate preventive screenings for conditions such as diabetic retinopathy, cardiovascular risk, and other systemic diseases directly into routine care, making retinal screening as simple and ubiquitous as measuring blood pressure.

“The next frontier in healthcare isn’t just treating disease - it’s detecting it early and keeping people well. identifeye HEALTH is turning advanced science into practical tools that give clinicians a clear window into health, strengthening the physician–patient relationship and enabling truly preventive care. I am excited to help guide this mission as it connects early detection, patient engagement, and the broader movement toward longevity and better living.” - Dr. Jordan Shlain, Founder, Private Medical; Co-Founder, DOC Health.

“Scaling preventive diagnostics takes more than breakthrough technology; it takes purpose, precision, and perseverance,” said J eff Huber, Founding CEO of GRAIL and former SVP at Google and Google [x]. “At GRAIL, our guiding principle was simple yet profound: detect disease early, when it can be cured. identifeye HEALTH embodies that same spirit, applying AI and automation to bring actionable insights directly to the point of care. Having worked with Vicky at both X and GRAIL, I’ve seen her unique ability to bridge vision and execution. The result is a platform that has the potential to transform how we approach prevention and population health.”

Clinical, Commercial and Scientific Advisory Panel Members include:

• Ron Adelman, MD, MPH, MBA, FACS: Chair of the Department of Ophthalmology at Mayo Clinic, Former Retina and Macula Center at Yale

• Elazer Edelman, MD, PhD: Director of the Institute of Medical Engineering and Science at MIT

• Jeff Huber, MBA: Founding CEO of GRAIL, Former SVP of Google Ads, Apps, Maps & [x], Managing Partner at Triatomic Capital

• Brian Litt, MD: Director of the Penn Center for Health, Devices and Technology at the University of Pennsylvania

• Lindsay Rhodes MD, MSPH: Ophthalmologist, Former Director of Teleophthalmology, University of Alabama

• David Rosenthal, MD: Primary Care Physician, Yale School of Medicine and Center for Biomedical Innovation and Technology

• Dennis Ausiello, MD: Director of CATCH, Former Chief of Medicine at Mass General, Distinguished Professor at Harvard Medical

• Dorothy Hitchmoth, OD: Former Chief of Optometry for U.S. Department of Veterans Affairs, health-tech Clinical & Medical Advisor

• Arthur Klein, MD: President Emeritus of Mt Sinai, Clinical Professor of Pediatrics & Admin at NYIT, adjunct faculty at the Mailman School of Public Health of Columbia

• Shaden Marzouk, MD, MBA: CEO of Genesis Care U.S., Former President & CEO of CareMore and Aspire Health, Former CMO at Cardinal Health

• Jordan Shlain, MD: Founder & Chairman at Private Medical, health-tech Clinical & Medical Advisor and Entrepreneur

• John Martin, MD, MBA: President & Founder of the Heart Health Foundation, Chief Medical Officer Emeritus at Butterfly Network

• Leslie Courtney, MS: CCO at SOMETHINGS, Former CCO at BeMe Health, Former EVP Client Success at Papa

• Robert Strony, DO, MBA, FAEMUS: CEO at Clinical Ultrasound Solutions LLC, Chief Population Health Officer at UPMC North Central Region, Managing Member at StrongURcare, Former Medical Director at Geisinger

• Harlan Krumholz, MD, SM: Harold H. Hines Professor of Medicine at Yale University, Director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation (CORE)

About identifeye HEALTH

identifeye HEALTH is redefining preventive diagnostics through accessible, AI-enabled retinal imaging. The company’s intuitive platform uses advanced imaging and automation to empower frontline care teams, enhance efficiency, and improve outcomes. By bringing care closer to patients, identifeye HEALTH aims to make early detection and intervention part of every routine visit.

Contact Information

Brook Fowler

VSC for identifeye HEALTH

VSC

identifeye@vsc.co